R21AT013004
Project Grant
Overview
Grant Description
Screening of US and Jordanian natural product libraries for the discovery of blood brain barrier (BBB) penetrant cathepsin L inhibitors for the treatment of chronic pain.
Funding Goals
NOT APPLICABLE
Grant Program (CFDA)
Awarding / Funding Agency
Place of Performance
La Jolla,
California
920930212
United States
Geographic Scope
Single Zip Code
Related Opportunity
Analysis Notes
Amendment Since initial award the total obligations have increased 1% from $336,701 to $341,701.
San Diego University Of California was awarded
BBB-Penetrant Cathepsin L Inhibitors for Chronic Pain Treatment
Project Grant R21AT013004
worth $341,701
from National Center for Complementary and Integrative Health in September 2024 with work to be completed primarily in La Jolla California United States.
The grant
has a duration of 2 years and
was awarded through assistance program 93.213 Research and Training in Complementary and Integrative Health.
The Project Grant was awarded through grant opportunity Global Brain and Nervous System Disorders Research Across the Lifespan (R21 Clinical Trial Optional).
Status
(Ongoing)
Last Modified 9/20/24
Period of Performance
9/13/24
Start Date
8/31/26
End Date
Funding Split
$341.7K
Federal Obligation
$0.0
Non-Federal Obligation
$341.7K
Total Obligated
Activity Timeline
Transaction History
Modifications to R21AT013004
Additional Detail
Award ID FAIN
R21AT013004
SAI Number
R21AT013004-3785580196
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
Public/State Controlled Institution Of Higher Education
Awarding Office
75NY00 NIH NATIONAL CENTER FOR COMPLEMENTARY & INTEGRATIVE HEALTH
Funding Office
75NY00 NIH NATIONAL CENTER FOR COMPLEMENTARY & INTEGRATIVE HEALTH
Awardee UEI
UYTTZT6G9DT1
Awardee CAGE
50854
Performance District
CA-50
Senators
Dianne Feinstein
Alejandro Padilla
Alejandro Padilla
Modified: 9/20/24